GlassScriptPhysician profile
Majd Kanbour
NPI 1427346501
$17,788.49
in general payments reported to CMS, 2019-2025
37 companies · $1,743 in 2025
The $1,743 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,154 · 2020: $1,291 · 2021: $1,398 · 2022: $3,688 · 2023: $1,536 · 2024: $978 · 2025: $1,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,158 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,158.02 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $6,766.46 | 2019 | |
| Penumbra, INC. | $2,458.10 | 2022-2024 | Indigo System |
| Medtronic, INC. | $1,122.47 | 2021-2024 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $1,007.01 | 2022-2025 | |
| Edwards Lifesciences Corporation | $881.10 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $739.59 | 2020-2025 | Lifevest |
| Inari Medical, INC. | $543.68 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $532.26 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $530.03 | 2019-2025 | Ranger, Ekosonic, Watchman Flx |
| Cardiovascular Systems INC. | $478.20 | 2019-2022 | |
| Abiomed | $361.35 | 2023-2025 | Impella |
| Merck Sharp & Dohme LLC | $281.89 | 2022-2025 | Verquvo |
| Abbott Laboratories | $277.78 | 2021-2025 | Emboshield Nav6, Cardiomems, Perclose Prostyle |
| Janssen Pharmaceuticals, INC | $209.10 | 2022-2024 | Xarelto |
| Ge Healthcare | $163.34 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $152.02 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.02 | 2023-2024 | Jardiance |
| Pfizer INC. | $127.18 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $117.31 | 2025 | Opsumit, Uptravi, Opsynvi |
| Bard Peripheral Vascular, INC. | $102.21 | 2021-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Fluency Endovascular Stent Graft |
| E.R. Squibb & Sons, L.L.C. | $99.06 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.10 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $93.72 | 2023-2025 | Wainua, Brilinta |
| Kestra Medical Technology Services, INC. | $68.07 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $67.49 | 2022-2023 | Cleviprex, Kengreal |
| Cook Medical LLC | $53.41 | 2020 | |
| Philips North America LLC | $51.43 | 2020-2023 | |
| Novo Nordisk INC | $51.23 | 2022-2025 | Wegovy |
| Nuwellis, INC. | $37.06 | 2023 | Aquadex Smartflow Console |
| Esperion Therapeutics, INC. | $33.20 | 2024-2025 | Nexletol |
| Scpharmaceuticals INC. | $28.96 | 2024 | |
| Veryan Medical Incorporated | $25.92 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.84 | 2024 | Onpattro |
| Teleflex LLC | $18.72 | 2025 | Trapliner |
| Cordis US Corp. | $17.70 | 2025 | Mynx Control Venous |
| Ultragenyx Pharmaceutical INC. | $16.84 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $13.64 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Majd Kanbour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.